T he prescription painkiller originally known as Vioxx may be making a comeback after its maker, Merck, abruptly pulled it from the market in 2004 following studies that showed the drug roughly ...

Merck’s Vioxx, a member of a class of anti-inflammatory drugs called COX-2 inhibitors, was flying high when it was launched in 1999. It boasted remarkable arthritis pain relief, yet didn’t ...

S ince its recall in 2004, the pain drug Vioxx has been a symbol of pharmaceutical danger, starring in countless daytime legal advertisements explaining how you, or perhaps a loved one, might be ...

Now tiny Tremeau Pharmaceuticals is working to bring it back, to treat severe joint pain caused by the bleeding disorder hemophilia. That's for far fewer patients than the millions who took Vioxx ...

U.S. drugmaker Merck & Co on Friday said it would pay $830 million to settle a federal class action lawsuit involving allegations the company failed to adequately inform investors about heart ...

Rofecoxib (Photo credit: Wikipedia) More than a decade ago, Merck launched Vioxx (rofecoxib), one of the first of a new class of pain relievers known as COX-2 inhibitors. These compounds, by ...

The Vioxx story in Australia may well have a third chapter to be written, as Mr Peterson may choose to seek leave to appeal to the High Court of Australia.

An Australian appeals court has negated a Vioxx-related ruling against Merck's domestic unit. The decision overturns last year's award of about $280,000 in damages to Vioxx patient Graeme Peterson, ...

NEW YORK (Reuters Health) - Merck's withdrawn painkiller Vioxx may have continued to cause blood clots and perhaps deaths even after patients dropped it, U.S. researchers said Monday. The drug was ...

The withdrawal of Merck’s “super aspirin,” the COX-2 specific inhibitor Vioxx from the market may be as distant as the 2004 Bush-Kerry presidential election in the public’s memory. But it ...

This morning, a report on Vioxx published by the Annals of Internal Medicine has reached a startling conclusion. Merck’s original study on the drug’s side effects was done primarily to support ...